Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer
Investigation of the effects of daily sildenafil on patients with pancreatic or cholangiocarcinoma cancer undergoing treatment.
Pancreatic Cancer|Cholangiocarcinoma
DRUG: Sildenafil
Lean Body Mass, Lean body mass will be measured by DEXA scan, 4 weeks|Skeletal Muscle Fatigue, Skeletal muscle fatigue will be measured by leg dynamometer., 4 weeks
This is a double-blinded, placebo-controlled trial in men and women, 40-75 years old, diagnosed with pancreatic or cholangiocarcinoma cancer. Patients will receive placebo or sildenafil daily for 4 weeks during their initial chemotherapy cycle.